Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
64.81
+0.30 (0.47%)
At close: Mar 2, 2026, 4:00 PM EST
64.81
0.00 (0.00%)
After-hours: Mar 2, 2026, 5:58 PM EST
Inspire Medical Systems Stock Forecast
Stock Price Forecast
The 14 analysts that cover Inspire Medical Systems stock have a consensus rating of "Buy" and an average price target of $102.86, which forecasts a 58.71% increase in the stock price over the next year. The lowest target is $66 and the highest is $175.
Price Target: $102.86 (+58.71%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Inspire Medical Systems stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 3 | 3 | 2 |
| Buy | 5 | 5 | 6 | 7 | 6 | 4 |
| Hold | 7 | 8 | 5 | 6 | 7 | 10 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 15 | 14 | 16 | 16 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wolfe Research | Wolfe Research | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Feb 13, 2026 |
| Jefferies | Jefferies | Hold Maintains $81 → $66 | Hold | Maintains | $81 → $66 | +1.84% | Feb 12, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $90 → $68 | Hold | Maintains | $90 → $68 | +4.92% | Feb 12, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $165 → $85 | Buy | Maintains | $165 → $85 | +31.15% | Feb 12, 2026 |
| Truist Securities | Truist Securities | Hold Maintains $96 → $70 | Hold | Maintains | $96 → $70 | +8.01% | Feb 12, 2026 |
Financial Forecast
Revenue This Year
991.28M
from 911.98M
Increased by 8.70%
Revenue Next Year
1.08B
from 991.28M
Increased by 9.05%
EPS This Year
1.76
from 4.89
Decreased by -63.95%
EPS Next Year
2.57
from 1.76
Increased by 45.56%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 1.1B | 1.2B | |||
| Avg | 991.3M | 1.1B | |||
| Low | 932.3M | 993.3M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 15.9% | 18.2% | |||
| Avg | 8.7% | 9.1% | |||
| Low | 2.2% | 0.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 2.43 | 3.74 | |||
| Avg | 1.76 | 2.57 | |||
| Low | 1.33 | 1.58 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -50.4% | 112.0% | |||
| Avg | -63.9% | 45.6% | |||
| Low | -72.7% | -10.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.